STOCK TITAN

Insider Notice: 1,193 CVKD Founder Shares Proposed for Sale on 08/28/2025

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for proposed sale of securities under Rule 144. The filing shows an intended sale of 1,193 common shares through Merrill Lynch on 08/28/2025 with an aggregate market value of $16,540.64. The shares were acquired as founders shares on 01/25/2022 from the company. The filing reports 2,046,854 shares outstanding for the class listed. Separately, the document discloses a recent sale by Quang Pham of 3,836 common shares on 08/27/2025 that generated $53,455.56 in gross proceeds. The issuer name and CIK are not provided in the visible content, and the filer contact details are blank.

Positive

  • Required sale details provided: share counts, dates, broker, and aggregate values are included for the proposed sale and recent sale
  • Acquisition history disclosed: the filing states the shares were founders shares acquired 01/25/2022, clarifying origin

Negative

  • Issuer and filer identifiers missing: the issuer name and CIK are not provided in the visible content, limiting verification
  • Contact information blank: submission contact details and filer CIK/CCC are not present, reducing traceability

Insights

TL;DR: Routine insider resale notice showing small founder and recent sale activity; missing issuer identifiers limit immediate tracking.

The filing documents a proposed resale of 1,193 common shares acquired as founders shares on 01/25/2022, to be executed via Merrill Lynch on 08/28/2025 for $16,540.64 aggregate market value. It also discloses a prior sale by Quang Pham of 3,836 shares on 08/27/2025 for $53,455.56. From a compliance perspective, the form records necessary sale details and acquisition history consistent with Rule 144 reporting. However, the absence of the issuer name and CIK in the provided content reduces the ability to cross-check insider status, holding limits, or aggregation with other filings.

TL;DR: Disclosure appears routine and non-material given amounts; incomplete issuer identification is a practical issue for stakeholders.

The amounts disclosed—1,193 shares (~$16.5k) proposed and a recent 3,836-share sale (~$53.5k)—are modest relative to typical market caps and do not in themselves indicate material corporate change. The acquisition entry shows these were founders shares dated 01/25/2022, which clarifies origin. For governance monitoring, the missing issuer name and filer identifiers are notable gaps that should be resolved to confirm insider relationship and any blackout or trading-plan context.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for CVKD disclose about the proposed sale?

The filing shows a proposed sale of 1,193 common shares via Merrill Lynch on 08/28/2025 with an aggregate market value of $16,540.64.

When and how were the shares being sold acquired?

The 1,193 shares were acquired as founders shares on 01/25/2022 from the company.

Did the filer sell any shares recently prior to this proposed sale?

Yes. The document reports Quang Pham sold 3,836 common shares on 08/27/2025 for $53,455.56 in gross proceeds.

Which broker is handling the proposed sale?

The broker listed for the proposed sale is Merrill Lynch with an address in Ponte Vedra Beach, FL.

Are there any missing details that affect how investors can verify this filing?

Yes. The visible content does not include the issuer name, CIK, or complete filer contact information, which limits external verification.
Cadrenal Therape

NASDAQ:CVKD

CVKD Rankings

CVKD Latest News

CVKD Latest SEC Filings

CVKD Stock Data

17.33M
1.81M
27.84%
7.23%
0.55%
Biotechnology
Pharmaceutical Preparations
Link
United States
PONTE VEDRA